Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;64(3):750-752.
doi: 10.1080/10428194.2023.2172981. Epub 2023 Feb 1.

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy

Affiliations

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy

Konstantinos Lontos et al. Leuk Lymphoma. 2023 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest disclosure: Annie Im has performed consulting from Abbvie and CTI Biopharma and received research funding from Incyte. Alison Sehgal has received research funding from Kite/Gilead, Juno/BMS and Milltenyiz. Michael Boyiadzis is currently an adjunct professor of Medicine at the University of Pittsburgh and an employee of Genentech.

References

    1. Dohner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N Engl J Med. Sep 17 2015;373(12):1136–52. doi:10.1056/NEJMra1406184 - DOI - PubMed
    1. Terry CM, Shallis RM, Estey E, Lim SH. Day 14 bone marrow examination in the management of acute myeloid leukemia. Am J Hematol. Oct 2017;92(10):1079–1084. doi:10.1002/ajh.24818 - DOI - PubMed
    1. NCCN Guidelines. Acute Myeloid Leukemia. Version 2.2022. https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf
    1. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. Dec 15 2003;21(24):4642–9. doi:10.1200/JCO.2003.04.036 - DOI - PubMed
    1. Chen X, Othus M, Wood BL, et al. Flow cytometric demonstration of decrease in bone marrow leukemic blasts after ‘Day 14’ without further therapy in acute myeloid leukemia. Leuk Lymphoma. Nov 2017;58(11):2717–2719. doi:10.1080/10428194.2017.1307359 - DOI - PubMed

Publication types